Full name
CENTRUM TANICH LEKÓW III CHOJNACKI SPÓŁKA JAWNA
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
70.22.Z - Head office activities and management consultancy
73.20.Z - Market research and public opinion polling
78.30.Z - Employment activities
96.09.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,1 | 0,2 | 0,2 | -26,4 |
Gross profit (loss) | 0,3 | 0,2 | 0,1 | -22,4 |
EBITDA | 0,3 | 0,2 | 0,1 | -25,9 |
Short time liabilities | 1,5 | 1,8 | 1,9 | 2,4 |
Other operating costs | 0,1 | 0,1 | 0 | -40,5 |
Equity capital | -0,4 | -0,2 | -0,1 | 65,6 |
Operating profit (EBIT) | 0,3 | 0,2 | 0,1 | -22,6 |
Assets | 1,4 | 1,8 | 1,9 | 5,7 |
Net profit (loss) | 0,3 | 0,2 | 0,1 | -22,4 |
Cash | 0,2 | 0,2 | 0,3 | 41,5 |
Net income from sale | 11,4 | 13,1 | 14,3 | 8,7 |
Liabilities and provisions for liabilities | 1,8 | 2 | 2 | -1,2 |
Working assets | 1,4 | 1,8 | 1,9 | 5,7 |
Other income costs | 0,2 | 0 | 0 | -39,3 |
Depreciation | 0 | 0 | 0 | -100 |
% | % | % | p.p. | |
Profitability of capital | -83,3 | -84,6 | -190,9 | -106,3 |
Equity capital to total assets | -25,8 | -10,8 | -3,5 | 7,3 |
Gross profit margin | 2,6 | 1,3 | 0,9 | -0,4 |
EBITDA Margin | 2,7 | 1,3 | 0,9 | -0,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 47 | 50 | 48 | -2 |
Current financial liquidity indicator | 0.9513927698135376 | 1.0017828941345215 | 1.0338126420974731 | 0 |
Net dept to EBITDA | 0.028363345190882683 | -0.7784293293952942 | -2.108929395675659 | -1,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane